Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 20.89 | 27.12 | 16.72 | 22.75 | 24.55 | 21.99 | 28.40 | 33.58 | 33.55 | 18.79 | 23.75 | 14.36 | 147.59 | 22.31 | 21.67 | 23.84 | 275.54 | 55.02 | 42.14 | 32.50 | 54.10 |
| — | +23.3% | -41.1% | -32.3% | -26.8% | +17.0% | +19.6% | +133.9% | -77.3% | -15.8% | +9.6% | -39.8% | -46.4% | -59.4% | -48.6% | -26.6% | +409.3% | -22.0% | -52.0% | +72.3% | +24.7% | |
| P/S Ratio | 3.05 | 4.73 | 2.72 | 3.35 | 3.16 | 2.76 | 3.41 | 4.07 | 3.29 | 2.28 | 2.59 | 1.75 | 1.85 | 1.72 | 1.88 | 1.94 | 2.09 | 1.87 | 2.68 | 2.78 | 2.40 |
| — | +71.7% | -20.1% | -17.7% | -4.0% | +20.9% | +31.8% | +132.1% | +77.5% | +32.8% | +37.9% | -9.7% | -11.4% | -8.1% | -30.0% | -30.1% | -13.1% | -29.6% | +0.4% | +20.5% | -17.6% | |
| P/B Ratio | 4.37 | 6.81 | 4.12 | 5.57 | 4.76 | 4.44 | 4.87 | 6.07 | 4.65 | 3.04 | 3.38 | 2.38 | 2.39 | 2.48 | 2.49 | 2.58 | 2.61 | 2.46 | 3.20 | 3.40 | 2.91 |
| — | +53.4% | -15.4% | -8.2% | +2.5% | +46.2% | +44.3% | +155.0% | +94.7% | +22.4% | +35.6% | -7.7% | -8.5% | +0.7% | -22.2% | -24.2% | -10.3% | -20.5% | +12.0% | +25.6% | -3.8% | |
| P/FCF | 24.32 | 33.69 | 15.20 | 19.21 | — | 12.95 | 23.15 | 22.70 | 21.22 | 7.61 | 28.36 | 7.06 | — | 40.84 | 202.20 | 25.22 | — | — | — | 177.96 | — |
| — | +160.2% | -34.3% | -15.4% | — | +70.2% | -18.4% | +221.5% | — | -81.4% | -86.0% | -72.0% | — | — | — | -85.8% | — | — | — | +413.0% | — | |
| EV / EBITDA | 13.68 | 21.19 | 11.44 | 15.43 | 17.00 | 12.10 | 20.51 | 22.07 | 20.73 | 11.71 | 16.10 | 8.67 | 59.20 | 12.79 | 16.14 | 14.63 | 104.93 | 29.27 | 23.89 | 21.25 | 30.63 |
| — | +75.1% | -44.2% | -30.1% | -18.0% | +3.3% | +27.4% | +154.7% | -65.0% | -8.4% | -0.2% | -40.8% | -43.6% | -56.3% | -32.4% | -31.1% | +242.6% | +6.2% | -54.7% | +94.3% | +23.2% | |
| EV / EBIT | 14.74 | 22.69 | 12.00 | 16.05 | 17.75 | 13.91 | 21.77 | 23.06 | 20.98 | 11.94 | 16.82 | 9.47 | 148.41 | 14.43 | 17.52 | 16.53 | 472.19 | 38.43 | 28.67 | 24.05 | 39.62 |
| — | +63.2% | -44.9% | -30.4% | -15.4% | +16.5% | +29.4% | +143.5% | -85.9% | -17.3% | -4.0% | -42.7% | -68.6% | -62.5% | -38.9% | -31.3% | +1091.7% | +12.9% | -65.8% | +100.8% | +27.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.5% | 78.7% | 78.8% | 78.4% | 78.1% | 78.3% | 78.0% | 77.7% | 78.3% | 76.2% | 74.8% | 77.0% | 77.1% | 76.8% | 75.0% | 74.0% | 78.2% | 72.0% | 76.4% | 76.9% | 77.0% |
| — | +0.5% | +1.1% | +1.0% | -0.2% | +2.8% | +4.2% | +0.8% | +1.6% | -0.8% | -0.3% | +4.1% | -1.4% | +6.6% | -1.7% | -3.7% | +1.5% | -1.6% | +0.1% | -3.0% | +0.2% | |
| Operating Margin | 18.8% | 19.7% | 20.3% | 19.2% | 15.8% | 18.7% | 13.6% | 15.6% | 13.2% | 15.7% | 13.3% | 16.5% | 1.2% | 11.0% | 9.9% | 10.9% | 0.4% | 4.4% | 8.5% | 10.5% | 5.4% |
| — | +5.4% | +48.6% | +22.5% | +19.7% | +18.8% | +2.8% | -5.4% | +1046.7% | +43.4% | +33.9% | +52.2% | +179.1% | +149.9% | +16.5% | +3.5% | -92.3% | -36.1% | +207.7% | -37.0% | -35.1% | |
| Net Margin | 15.3% | 17.5% | 16.2% | 14.6% | 12.6% | 12.7% | 12.1% | 12.1% | 10.0% | 12.3% | 10.8% | 12.2% | 1.3% | 7.6% | 8.9% | 8.3% | 0.8% | 3.4% | 6.4% | 8.2% | 4.4% |
| — | +38.2% | +34.1% | +20.7% | +25.9% | +2.8% | +12.0% | -1.0% | +699.0% | +62.4% | +20.8% | +46.8% | +65.5% | +123.3% | +40.1% | +1.9% | -82.7% | -19.5% | +149.5% | -35.5% | -34.3% |
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 23.3% | 6.6% | 6.3% | 6.1% | 4.9% | 5.1% | 4.3% | 4.6% | 3.4% | 4.2% | 3.6% | 4.3% | 0.4% | 2.8% | 3.0% | 2.8% | 0.2% | 1.1% | 1.9% | 2.5% | 1.3% |
| — | +30.4% | +46.9% | +32.4% | +41.7% | +20.5% | +19.9% | +8.5% | +738.8% | +50.5% | +20.2% | +51.6% | +72.3% | +148.3% | +56.8% | +11.6% | -82.3% | -8.2% | +178.2% | -33.9% | -23.4% | |
| ROA | 18.8% | 5.4% | 5.3% | 5.1% | 4.0% | 4.1% | 3.6% | 3.9% | 2.9% | 3.6% | 3.1% | 3.7% | 0.3% | 2.3% | 2.6% | 2.4% | 0.2% | 1.0% | 1.7% | 2.2% | 1.2% |
| — | +30.4% | +45.4% | +30.8% | +36.5% | +14.8% | +15.9% | +5.8% | +745.0% | +55.1% | +22.0% | +53.5% | +73.5% | +144.6% | +52.8% | +8.8% | -83.0% | -11.4% | +172.2% | -35.8% | -26.0% | |
| ROIC | 33.7% | 8.7% | 8.8% | 8.7% | 6.8% | 8.6% | 5.7% | 6.9% | 5.2% | 5.9% | 4.5% | 5.5% | 0.3% | 3.7% | 3.1% | 3.4% | 0.1% | 1.5% | 2.7% | 3.6% | 1.9% |
| — | +1.4% | +54.5% | +25.6% | +31.5% | +45.6% | +26.0% | +24.9% | +1399.3% | +58.1% | +46.9% | +64.2% | +183.6% | +152.4% | +12.8% | -5.3% | -93.5% | -37.9% | +208.5% | -39.4% | -24.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -46.2% | — | -14.7% | +1173.6% | +134.6% | — | -20.1% | -89.2% | -54.3% | -11.5% | +231.8% | +64.1% | +256.2% | -34.8% | -68.1% | -69.9% | -55.3% | -58.6% | +113.2% | +81.3% | |
| Debt / EBITDA | 0.01 | 0.03 | 0.02 | 0.02 | 0.04 | 0.05 | — | 0.04 | 0.00 | 0.03 | 0.02 | 0.05 | 0.19 | 0.10 | 0.02 | 0.02 | 0.19 | 0.06 | 0.04 | 0.08 | 0.17 |
| — | -40.2% | — | -35.5% | +913.1% | +58.7% | — | -24.1% | -98.1% | -64.2% | -34.5% | +120.5% | +2.2% | +51.5% | -44.4% | -71.5% | +9.3% | -41.7% | -84.0% | +214.3% | +130.6% | |
| Current Ratio | 4.69 | 4.69 | 4.91 | 4.86 | 5.09 | 4.31 | 5.19 | 5.10 | 5.53 | 5.75 | 6.53 | 5.97 | 6.27 | 4.69 | 5.48 | 5.68 | 5.58 | 4.83 | 6.64 | 6.95 | 6.74 |
| — | +9.0% | -5.4% | -4.7% | -8.0% | -25.2% | -20.5% | -14.7% | -11.8% | +22.6% | +19.2% | +5.1% | +12.3% | -2.9% | -17.5% | -18.2% | -17.2% | -29.3% | -12.8% | -21.6% | -18.9% | |
| Quick Ratio | 4.39 | 4.39 | 4.59 | 4.49 | 4.66 | 3.99 | 4.84 | 4.74 | 5.06 | 5.27 | 5.87 | 5.25 | 5.49 | 4.17 | 4.94 | 5.11 | 4.96 | 4.39 | 6.22 | 6.57 | 6.32 |
| — | +10.1% | -5.3% | -5.3% | -8.1% | -24.3% | -17.5% | -9.6% | -7.8% | +26.4% | +18.8% | +2.8% | +10.6% | -5.0% | -20.6% | -22.2% | -21.5% | -31.2% | -12.2% | -19.1% | -15.1% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ELMD stock.
Electromed, Inc.'s current P/E is 20.9x. The average P/E over the last 4 quarters is 22.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Electromed, Inc.'s current operating margin is 18.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Electromed, Inc.'s business trajectory between earnings reports.